Shady, hawks has been taking too many Deep State pharma

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 Shady #12235
635
Shady, hawks has been taking too many Deep State pharma products, you know, the same Deep State he says does not exist, yet backs 100%

How Rockefeller Founded Big Pharma And Waged War On Natural Cures
March 27, 2018 Baxter Dmitry Health 75


https://yournewswire.com/rockefeller-big-phar...ral-cures/


John D. Rockefeller laid the groundwork for the pharmaceutical industry to become a monster that wages war on natural cures.

Western medicine has some good points, and is great in an emergency, but it’s high time people realized that today’s mainstream medicine (western medicine or allopathy), with its focus on drugs, drugs, radiation, drugs, surgery, drugs and more drugs, is at its foundation a money spinning Rockefeller creation.

People these days look at you like a weirdo if you talk about the healing properties of plants or any other holistic practices. Much like anything else, politics and money have been used to warp people’s minds and encourage them to embrace what is bad for them.

It all began with John D. Rockefeller (1839 – 1937) who was an oil magnate, a robber baron, America’s first billionaire, and a natural-born monopolist.

By the turn on the 20th century, he controlled 90% of all oil refineries in the U.S. through his oil company, Standard Oil, which was later on broken up to become Chevron, Exxon, Mobil etc.

Rockefeller-big-pharma

World Affairs reports: At the same time, around 1900, scientists discovered “petrochemicals” and the ability to create all kinds of chemicals from oil. For example, the first plastic — called Bakelite — was made from oil in 1907. Scientists were discovering various vitamins and guessed that many pharmaceutical drugs could be made from oil.

This was a wonderful opportunity for Rockefeller who saw the ability to monopolize the oil, chemical and the medical industries at the same time!

The best thing about petrochemicals was that everything could be patented and sold for high profits.

But there was one problem with Rockefeller’s plan for the medical industry: natural/herbal medicines were very popular in America at that time. Almost half the doctors and medical colleges in the U.S. were practicing holistic medicine, using knowledge from Europe and Native Americans.

Rockefeller, the monopolist, had to figure out a way to get rid of his biggest competition. So he used the classic strategy of “problem-reaction-solution.” That is, create a problem and scare people, and then offer a (pre-planned) solution. (Similar to terrorism scare, followed by the “Patriot Act”).

He went to his buddy Andrew Carnegie – another plutocrat who made his money from monopolizing the steel industry – who devised a scheme. From the prestigious Carnegie Foundation, they sent a man named Abraham Flexner to travel around the country and report on the status of medical colleges and hospitals around the country.

This led to the Flexner Report, which gave birth to the modern medicine as we know it.

Needless to say, the report talked about the need for revamping and centralizing our medical institutions. Based on this report, more than half of all medical colleges were soon closed.

Homeopathy and natural medicines were mocked and demonized; and doctors were even jailed.

To help with the transition and change the minds of other doctors and scientists, Rockefeller gave more than $100 million to colleges, hospitals and founded a philanthropic front group called “General Education Board” (GEB). This is the classic carrot and stick approach.

In a very short time, medical colleges were all streamlined and homogenized. All the students were learning the same thing, and medicine was all about using patented drugs.

Scientists received huge grants to study how plants cured diseases, but their goal was to first identify which chemicals in the plant were effective, and then recreate a similar chemical – but not identical – in the lab that could be patented.

A pill for an ill became the mantra for modern medicine.

And you thought Koch brothers were evil?

So, now we are, 100 years later, churning out doctors who know nothing about the benefits of nutrition or herbs or any holistic practices. We have an entire society that is enslaved to corporations for its well-being.

America spends 15% of its GDP on healthcare, which should be really called “sick care.” It is focused not on cure, but only on symptoms, thus creating repeat customers. There is no cure for cancer, diabetes, autism, asthma, or even flu.

Why would there be real cures? This is a system founded by oligarchs and plutocrats, not by doctors.

As for cancer, oh yeah, the American Cancer Society was founded by none other than Rockefeller in 1913.

In this month of breast cancer awareness, it is sad to see people being brainwashed about chemotherapy, radiation and surgery. That’s for another blog post … but here is a quote from John D. Rockefeller that summarizes his New World Order vision for America…
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boots Group Wraps Up Consent Solicitation for Notes

Updated Category News Views 3

Consent Solicitation's Critical Role in Acquisition No time for dawdling—Boots Group's gathered up their consent cards for hefty senior secured notes, and we're talking close to a billion smackers here. It's a bold move to grease the wheels on looming acquisition maneuvers. We're looking at a €650 million and a £375 million stack of senior secured notes patiently...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Gildan Activewear Faces 18.8% Hit Amid Securities Suit

Updated Category News Views 3

Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 34

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 38

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 135

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 21

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading

Top 5 Most Recently Viewed Articles

Lamar Advertising to Engage at Major CEO Conference in 2025

Updated Category News Views 226

Exciting Participation at the Citi 2025 Global Property CEO Conference Lamar Advertising Company (Nasdaq: LAMR), a leading name in outdoor advertising, is gearing up for a significant appearance at the upcoming Citi 2025 Global Property CEO Conference. Scheduled for March 3, 2025, Sean Reilly, the company's CEO, will take center stage to engage in a lively...

Continue Reading
Venu Holding Corporation Explores Partnership with Troy Aikman

Updated Category News Views 214

Venu Holding Corporation Explores Partnership with Troy Aikman Venu Holding Corporation (“VENU”) (NYSE American: VENU) has exciting news to share! Recently, an exclusive interview was presented on TMZ Sports featuring NFL Hall of Famer Troy Aikman, who is also the owner of EIGHT Elite Light Lager, alongside J.W. Roth, the talented Founder, Chairman, and CEO of VENU....

Continue Reading
Third Century Bancorp's Commitment to Shareholder Dividends

Updated Category News Views 43

Third Century Bancorp Declares Dividend Third Century Bancorp (OTCPINK: TDCB), the parent company of Mutual Savings Bank, has made a noteworthy announcement about its dedication to enhancing shareholder value. The company has declared a dividend of $0.05 per share, reflecting its solid financial health. Shareholders should note that this dividend is applicable to those...

Continue Reading
Discover Modern Meadow's Exciting Innovations at Lineapelle 2025

Updated Category News Views 353

Modern Meadow Showcases Innovations at Lineapelle 2025 Modern Meadow, a pioneer in sustainable materials, is set to make waves at the upcoming Lineapelle 2025 exhibition. This prestigious event, dedicated to the world of leather and related products, offers an excellent platform for showcasing their advanced, renewable biomaterials. Visitors can find Modern Meadow in Hall...

Continue Reading
C3 AI Plans Financial Results Announcement for Q3 FY2025

Updated Category News Views 285

C3 AI Plans Financial Results Announcement for Q3 FY2025 C3 AI (NYSE: AI), the leader in enterprise AI application software, is set to share its financial performance for the third quarter of the fiscal year 2025. This significant event is scheduled to happen after the close of the U.S. markets, marking an important moment for the company and its stakeholders....

Continue Reading